PubRank

S R Hanson

Author PubWeight™ 88.98‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Age-related changes in human lens crystallins identified by two-dimensional electrophoresis and mass spectrometry. Exp Eye Res 1998 1.88
2 Experimental acute thrombotic stroke in baboons. Stroke 1987 1.64
3 Localizing antithrombotic and vasodilatory activity with a novel, ultrafast nitric oxide donor. J Med Chem 1996 1.54
4 Age-related changes in human lens crystallins identified by HPLC and mass spectrometry. Exp Eye Res 1998 1.53
5 Inhibition of thrombus formation by activated recombinant protein C in a primate model of arterial thrombosis. Circulation 1990 1.52
6 Antithrombotic effects of combining activated protein C and urokinase in nonhuman primates. Circulation 1991 1.47
7 Antithrombotic activity of protein S infused without activated protein C in a baboon thrombosis model. Thromb Haemost 2012 1.42
8 Mechanisms of arterial graft failure. 1. Role of cellular proliferation in early healing of PTFE prostheses. Am J Pathol 1985 1.40
9 Platelet kinetics in patients with bone marrow hypoplasia: evidence for a fixed platelet requirement. Blood 1985 1.18
10 Inhibition of platelet-dependent thrombosis by low molecular weight heparin (CY222): comparison with standard heparin. J Lab Clin Med 1989 1.14
11 Platelet reactivity in depressed patients treated with paroxetine: preliminary findings. Arch Gen Psychiatry 2000 1.12
12 Beta3 integrins are upregulated after vascular injury and modulate thrombospondin- and thrombin-induced proliferation of cultured smooth muscle cells. Circulation 1998 1.12
13 Oligomerization and phase separation in globular protein solutions. Biophys Chem 1998 1.10
14 A mechanistic model of acute platelet accumulation in thrombogenic stenoses. Ann Biomed Eng 2001 1.08
15 Inhibition of platelet-dependent thrombus formation by human activated protein C in a primate model. Blood 1989 1.08
16 Induction of vascular endothelial growth factor in balloon-injured baboon arteries. A novel role for reactive oxygen species in atherosclerosis. Circ Res 1997 1.06
17 Nitric oxide-releasing polymers containing the [N(O)NO]- group. J Med Chem 1996 1.05
18 In vivo evaluation of artificial surfaces with a nonhuman primate model of arterial thrombosis. J Lab Clin Med 1980 1.00
19 Platelet interactions with Dacron vascular grafts. A model of acute thrombosis in baboons. Arteriosclerosis 1985 0.99
20 Reduced thrombus formation by hyaluronic acid coating of endovascular devices. Arterioscler Thromb Vasc Biol 2000 0.98
21 Interruption of vascular thrombus formation and vascular lesion formation by dietary n-3 fatty acids in fish oil in nonhuman primates. Circulation 1993 0.96
22 A scaling law for wall shear rate through an arterial stenosis. J Biomech Eng 1994 0.96
23 The role of alpha and beta platelet-derived growth factor receptor in the vascular response to injury in nonhuman primates. Arterioscler Thromb Vasc Biol 1999 0.96
24 Effects of platelet-modifying drugs on arterial thromboembolism in baboons. Aspirin potentiates the antithrombotic actions of dipyridamole and sulfinpyrazone by mechanism(s) independent of platelet cyclooxygenase inhibition. J Clin Invest 1985 0.95
25 Dose-response effects of pegylated human megakaryocyte growth and development factor on platelet production and function in nonhuman primates. Blood 1996 0.95
26 Clopidogrel inhibition of stent, graft, and vascular thrombogenesis with antithrombotic enhancement by aspirin in nonhuman primates. Circulation 1998 0.94
27 Experimental arterial thromboembolism in baboons. Mechanism, quantitation, and pharmacologic prevention. J Clin Invest 1979 0.94
28 Antithrombotic strategies targeting thrombin activities, thrombin receptors and thrombin generation. Thromb Haemost 1997 0.91
29 Bileaflet aortic valve prosthesis pivot geometry influences platelet secretion and anionic phospholipid exposure. Ann Biomed Eng 2001 0.91
30 The relation of platelet density to platelet age: survival of low- and high-density 111indium-labeled platelets in baboons. Blood 1986 0.90
31 Hirudin interruption of heparin-resistant arterial thrombus formation in baboons. Blood 1991 0.90
32 Limited generation of activated protein C during infusion of the protein C activator thrombin analog W215A/E217A in primates. J Thromb Haemost 2006 0.90
33 Characterization of thrombin receptor expression during vascular lesion formation. Circ Res 1994 0.90
34 Prevention of thrombocytopenia and neutropenia in a nonhuman primate model of marrow suppressive chemotherapy by combining pegylated recombinant human megakaryocyte growth and development factor and recombinant human granulocyte colony-stimulating factor. Blood 1997 0.90
35 Regulation of platelet production and function by megakaryocyte growth and development factor in nonhuman primates. Blood 1996 0.90
36 Phosphorylcholine coating of ePTFE grafts reduces neointimal hyperplasia in canine model. Ann Vasc Surg 1997 0.90
37 Enhanced thrombolytic and antithrombotic potency of a fibrin-targeted plasminogen activator in baboons. Circulation 1996 0.90
38 Healing of polytetrafluoroethylene arterial grafts is influenced by graft porosity. J Vasc Surg 1990 0.89
39 On the multiplicity of platelet prostaglandin receptors. II. The use of N-0164 for distinguishing the loci of action for PGI2, PGD2, PGE2 and hydantoin analogs. Prostaglandins 1984 0.89
40 Prevention of acquired transient defect in platelet plug formation by infused prostacyclin. Blood 1981 0.88
41 Discrimination between platelet-mediated and coagulation-mediated mechanisms in a model of complex thrombus formation in vivo. J Lab Clin Med 1989 0.87
42 Methods and models to evaluate shear-dependent and surface reactivity-dependent antithrombotic efficacy. Thromb Res 2001 0.87
43 A novel method for efficient drug delivery. Ann Biomed Eng 1998 0.87
44 Enhanced in vivo antithrombotic effects of endothelial cells expressing recombinant plasminogen activators transduced with retroviral vectors. Circulation 1996 0.86
45 Relative antithrombotic effects of monoclonal antibodies targeting different platelet glycoprotein-adhesive molecule interactions in nonhuman primates. Blood 1994 0.85
46 Phosphorylcholine coating of ePTFE reduces platelet deposition and neointimal hyperplasia in arteriovenous grafts. J Surg Res 1998 0.85
47 Antithrombotic effects of synthetic peptides targeting various functional domains of thrombin. Proc Natl Acad Sci U S A 1992 0.85
48 Local infusion of heparin reduces anastomotic neointimal hyperplasia in aortoiliac expanded polytetrafluoroethylene bypass grafts in baboons. J Vasc Surg 2000 0.84
49 Antithrombotic and antilesion benefits without hemorrhagic risks by inhibiting tissue factor pathway. Haemostasis 1996 0.84
50 Boundary layer infusion of nitric oxide reduces early smooth muscle cell proliferation in the endarterectomized canine artery. J Surg Res 1997 0.84
51 Eptifibatide-induced thrombocytopenia and coronary bypass operation. J Thromb Haemost 2003 0.84
52 In vitro endothelialization of small-caliber vascular grafts. Surgery 1987 0.84
53 Effects of red blood cell concentration on hemostasis and thrombus formation in a primate model. Blood 1990 0.83
54 Monoclonal antibody-induced inhibition of platelet function: effects on hemostasis and vascular graft thrombosis in baboons. J Vasc Surg 1988 0.83
55 Correlation between prolonged bleeding time and depletion of platelet dense granule ADP in patients with myelodysplastic and myeloproliferative disorders. J Lab Clin Med 1984 0.83
56 Blood and tissue compatibility of modified polyester: thrombosis, inflammation, and healing. J Biomed Mater Res 1998 0.83
57 Boundary layer infusion of basic fibroblast growth factor accelerates intimal hyperplasia in endarterectomized canine artery. J Surg Res 1997 0.82
58 Factor V turnover in a primate model. Blood 1995 0.82
59 The sensitivity of indicators of thrombosis initiation to a bileaflet prosthesis leakage stimulus. J Heart Valve Dis 2001 0.82
60 RGDV peptide selectively inhibits platelet-dependent thrombus formation in vivo. Studies using a baboon model. J Clin Invest 1989 0.82
61 Biotinylated platelets: a new approach to the measurement of platelet life span. Br J Haematol 1993 0.81
62 Thrombin hypothesis of thrombus generation and vascular lesion formation. Am J Cardiol 1995 0.81
63 Studies of suloctidil in experimental thrombosis in baboons. Thromb Haemost 1985 0.81
64 Anti-VLA-4 antibody reduces intimal hyperplasia in the endarterectomized carotid artery in nonhuman primates. J Vasc Surg 1997 0.81
65 Antithrombotic effects of ionic and non-ionic contrast media in nonhuman primates. Thromb Haemost 2001 0.80
66 Confluent durable endothelialization of endarterectomized baboon aorta by early attachment of cultured endothelial cells. J Vasc Surg 1990 0.80
67 Local delivery of an antithrombin inhibits platelet-dependent thrombosis. Circulation 1994 0.80
68 In vivo and in vitro complexes of activated protein C with two inhibitors in baboons. Blood 1991 0.80
69 Selective inhibition by a synthetic hirudin peptide of fibrin-dependent thrombosis in baboons. Proc Natl Acad Sci U S A 1991 0.80
70 Interruption of vascular thrombosis by bolus anti-platelet glycoprotein IIb/IIIa monoclonal antibodies in baboons. J Vasc Surg 1993 0.79
71 Autologous platelet kinetics in patients with severe thrombocytopenia: discrimination between disorders of production and destruction. J Lab Clin Med 1991 0.79
72 Panel conference. Blood-materials interactions - 20 years of frustration. Trans Am Soc Artif Intern Organs 1981 0.79
73 Blood compatibility of surfaces modified by plasma polymerization. J Biomed Mater Res 1988 0.79
74 Antithrombotic benefits and hemorrhagic risks of direct thrombin antagonists. Thromb Haemost 1995 0.79
75 Local delivery of a synthetic antithrombin with a hydrogel-coated angioplasty balloon catheter inhibits platelet-dependent thrombosis. J Am Coll Cardiol 1994 0.79
76 Induction of transient neurological dysfunction in baboons by platelet microemboli. Stroke 1992 0.79
77 Nonporous silicone polymer coating of expanded polytetrafluoroethylene grafts reduces graft neointimal hyperplasia in dog and baboon models. J Vasc Surg 1996 0.78
78 Lasting safe interruption of endarterectomy thrombosis by transiently infused antithrombin peptide D-Phe-Pro-ArgCH2Cl in baboons. Blood 1993 0.78
79 Is smooth muscle growth in primate arteries regulated by endothelial nitric oxide synthase? J Vasc Surg 1998 0.78
80 Prevention of heparin-resistant thrombotic occlusion of hollow-fiber hemodialyzers by synthetic antithrombin. J Lab Clin Med 1989 0.78
81 Reduction in stent and vascular graft thrombosis and enhancement of thrombolysis by recombinant Lys-plasminogen in nonhuman primates. Circulation 1997 0.78
82 The kinetics of baboon fibrinogen adsorption to polymers: in vitro and in vivo studies. J Biomed Mater Res 1986 0.78
83 Thromboembolic potential of synthetic vascular grafts in baboons. J Vasc Surg 1989 0.78
84 Preformed confluent endothelial cell monolayers prevent early platelet deposition on vascular prostheses in baboons. J Vasc Surg 1988 0.78
85 Experimental arterial thrombosis in nonhuman primates. Circulation 1991 0.78
86 Recombinant mitotoxin basic fibroblast growth factor-saporin reduces venous anastomotic intimal hyperplasia in the arteriovenous graft. Circulation 1996 0.77
87 Iliac artery mural thrombus formation. Effect of antiplatelet therapy on 111In-platelet deposition in baboons. Arteriosclerosis 1986 0.77
88 Inhibition of platelet-dependent thrombosis by local delivery of heparin with a hydrogel-coated balloon. Circulation 1995 0.77
89 Antihemostatic and antithrombotic effects of monoclonal antibodies against von Willebrand factor in nonhuman primates. Surgery 1992 0.77
90 Synthesis and biological evaluation of myoseverin derivatives: microtubule assembly inhibitors. J Med Chem 2001 0.76
91 Antithrombotic potency of hirudin is increased in nonhuman primates by fibrin targeting. Circulation 1997 0.76
92 Pharmacologic modification of acute vascular graft thrombosis. Scan Electron Microsc 1982 0.76
93 Human and baboon integrin beta 5 subunit-encoding mRNAs have alternative polyadenylation sites. Gene 1993 0.76
94 Effects of a tetrafluoroethylene glow discharge on patency of small diameter dacron vascular grafts. Trans Am Soc Artif Intern Organs 1984 0.76
95 Reduction in vascular lesion formation by hirudin secreted from retrovirus-transduced confluent endothelial cells on vascular grafts in baboons. Circulation 1999 0.76
96 Effect of dazoxiben on arterial graft thrombosis in the baboon. Br J Clin Pharmacol 1983 0.75
97 Antithrombotic effects of orally active synthetic antagonist of activated factor X in nonhuman primates. Circulation 1995 0.75
98 Antithrombotic effects of synthetic pentasaccharide with high affinity for plasma antithrombin III in non-human primates. Thromb Haemost 1993 0.75
99 Local infusion of FGF-saporin reduces intimal hyperplasia. J Surg Res 1996 0.75
100 Identification of the glycation site of lens gamma B-crystallin by fast atom bombardment tandem mass spectrometry. Anal Biochem 1996 0.75
101 Ex vivo and in vitro platelet adhesion on RFGD deposited polymers. J Biomed Mater Res 1992 0.75
102 Factors influencing platelet consumption by polyacrylamide hydrogels. Ann Biomed Eng 1979 0.75
103 Alternative splicing of the mRNA encoding baboon glycoprotein receptor GPIIb. Gene 1994 0.75
104 Inhibition of thrombus formation in vivo by novel antiplatelet agent. Arteriosclerosis 1990 0.75
105 Thrombin-induced increase in surface expression of epitopes on platelet membrane glycoprotein IIb/IIIa complex and GMP-140 is a function of platelet age. Blood 1989 0.75
106 Production of transient ischaemic events by platelet emboli in baboons. Neurol Res 1992 0.75
107 cDNAs encoding the baboon thrombin receptor indicate a primate transcription start site upstream of putative sites reported for the human gene. Thromb Res 2000 0.75
108 Dermatan sulfate inhibition of fibrin-rich thrombus formation in nonhuman primates. Arterioscler Thromb 1993 0.75
109 Selective decrease in platelet dense granule adenine nucleotides during recovery from acute experimental thrombocytopenia and ensuing thrombocytosis in baboons. Br J Haematol 1988 0.75
110 Reduction in thrombus formation by placement of endovascular stents at endarterectomy sites in baboon carotid arteries. Circulation 1991 0.75
111 Survival of baboon platelets labeled with diazotized (125-1)-iodosulfanilic acid: no effect of drugs that modify platelet behavior. Thromb Res 1982 0.75
112 Boundary layer drug delivery using a helical catheter. J Control Release 1998 0.75
113 Reaction to injury following balloon angioplasty and intravascular stent placement in the canine femoral artery. Am Surg 1994 0.75
114 Platelet factors predisposing to arterial thrombosis. Baillieres Clin Haematol 1994 0.75
115 Heparin-resistant thrombus formation by endovascular stents in baboons. Interruption by a synthetic antithrombin. Circulation 1990 0.75
116 Platelet thromboembolism. Eur J Clin Invest 1994 0.75
117 Ex vivo and in vivo evaluation of drugs that inhibit platelet function. Ann N Y Acad Sci 1983 0.75
118 Boundary layer infusion of heparin prevents thrombosis and reduces neointimal hyperplasia in venous polytetrafluoroethylene grafts without systemic anticoagulation. J Vasc Surg 1995 0.75
119 Factors influencing acute thrombus formation on carotid artery vascular grafts. ASAIO Trans 1989 0.75
120 Potential new targets for antithrombotic therapy. Curr Pharm Des 2003 0.75
121 Duplex ultrasound analysis of operated carotid arteries in baboons. J Ultrasound Med 1990 0.75
122 Effective antiplatelet drug concentrations in experimental arterial thromboembolism. Thromb Res 1987 0.75
123 Exteriorized chronic aorto-caval arteriovenous access shunts in the baboon (Papio cynocephalus). J Med Primatol 1993 0.75
124 Characterization of a cDNA encoding the beta-chain of baboon receptor glycoprotein GPIb. Gene 1993 0.75
125 The progression of thrombus in an ex-vivo shunt model evaluated by intravascular ultrasound radiofrequency analysis. Ultrasound Med Biol 1999 0.75
126 Transgraft infusion of heparin to prevent early thrombosis of expanded PTFE grafts in canine femoral veins. Ann Vasc Surg 1996 0.75
127 Durability of confluent endothelial cell monolayers on small-caliber vascular prostheses in vitro. Surgery 1988 0.75